135 related articles for article (PubMed ID: 27473736)
1. Overview of Thoracic Oncology Trials in Cooperative Groups Around the Globe.
Salahudeen AA; Patel MI; Baas P; Curran WJ; Bradley JD; Gandara DR; Goss GD; Mok TS; Ramalingam SS; Vokes EE; Malik SM; Wakelee HA
Clin Lung Cancer; 2017 Jan; 18(1):5-12. PubMed ID: 27473736
[TBL] [Abstract][Full Text] [Related]
2. Update on International Cooperative Groups Studies in Thoracic Malignancies: The Emergence of Immunotherapy.
Shukla ND; Salahudeen AA; Taylor GA; Ramalingam SS; Vokes EE; Goss GD; Decker RH; Kelly K; Scagliotti GV; Mok TS; Wakelee HA
Clin Lung Cancer; 2018 Sep; 19(5):377-386. PubMed ID: 29653819
[TBL] [Abstract][Full Text] [Related]
3. Cooperative group research efforts in lung cancer 2008: focus on advanced-stage non-small-cell lung cancer.
Wakelee H; Kernstine K; Vokes E; Schiller J; Baas P; Saijo N; Adjei A; Goss G; Gaspar L; Gandara DR; Choy H; Putnam JB
Clin Lung Cancer; 2008 Nov; 9(6):346-51. PubMed ID: 19073517
[TBL] [Abstract][Full Text] [Related]
4. Summary of current cooperative group clinical trials in thoracic malignancies. The Thoracic Intergroup.
Rusch VW; Feins RH
Ann Thorac Surg; 1994 Jan; 57(1):102-6. PubMed ID: 8279873
[TBL] [Abstract][Full Text] [Related]
5. Cooperative group research efforts in thoracic malignancies 2009: a review from the 10th Annual International Lung Cancer Congress.
Wakelee H; Loo BW; Kernstine KH; Putnam JB; Edelman MJ; Vokes EE; Schiller JH; Baas P; Saijo N; Adjei A; Goss G; Choy H; Gandara DR
Clin Lung Cancer; 2009 Nov; 10(6):395-404. PubMed ID: 19900856
[TBL] [Abstract][Full Text] [Related]
6. Current standards of care in small-cell and non-small-cell lung cancer.
Schiller JH
Oncology; 2001; 61 Suppl 1():3-13. PubMed ID: 11598409
[TBL] [Abstract][Full Text] [Related]
7. Cooperative group portfolio in locally advanced non-small-cell lung cancer: are we making progress?
Langer CJ; Wakelee H; Schiller J; Choy H; Shepherd F; Vokes EE; Adjei AA; Baas P; Saijo N; Gandara DR
Clin Lung Cancer; 2008 Mar; 9(2):85-91. PubMed ID: 18501094
[TBL] [Abstract][Full Text] [Related]
8. Restrictive eligibility limits access to newer therapies in non-small-cell lung cancer: the implications of Eastern Cooperative Oncology Group 4599.
Somer RA; Sherman E; Langer CJ
Clin Lung Cancer; 2008 Mar; 9(2):102-5. PubMed ID: 18501096
[TBL] [Abstract][Full Text] [Related]
9. Cooperative trials in thoracic oncology are important.
Benfield JR
Ann Thorac Surg; 1994 Jan; 57(1):10-1. PubMed ID: 8279872
[No Abstract] [Full Text] [Related]
10. Changes in the natural history of nonsmall cell lung cancer (NSCLC)--comparison of outcomes and characteristics in patients with advanced NSCLC entered in Eastern Cooperative Oncology Group trials before and after 1990.
Wakelee HA; Bernardo P; Johnson DH; Schiller JH
Cancer; 2006 May; 106(10):2208-17. PubMed ID: 16604529
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy of PD-1/PD-L1 immune checkpoint inhibitors and PD-L1 testing in thoracic cancers].
Duruisseaux M; Rouquette I; Adam J; Cortot A; Cazes A; Gibault L; Damotte D; Lantuejoul S
Ann Pathol; 2017 Feb; 37(1):61-78. PubMed ID: 28162296
[TBL] [Abstract][Full Text] [Related]
12. Incorporation of paclitaxel and carboplatin in combined-modality therapy for locally advanced non-small cell lung cancer.
Belani CP
Semin Oncol; 1999 Feb; 26(1 Suppl 2):44-54. PubMed ID: 10190783
[TBL] [Abstract][Full Text] [Related]
13. The role of the Eastern Cooperative Oncology Group in establishing standards of cancer care: over 50 years of progress through clinical research.
Giantonio BJ; Forastiere AA; Comis RL;
Semin Oncol; 2008 Oct; 35(5):494-506. PubMed ID: 18929148
[TBL] [Abstract][Full Text] [Related]
14. A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group.
Segawa Y; Ueoka H; Kiura K; Kamei H; Tabata M; Sakae K; Hiraki Y; Kawahara S; Eguchi K; Hiraki S; Harada M
Br J Cancer; 2000 Jan; 82(1):104-11. PubMed ID: 10638975
[TBL] [Abstract][Full Text] [Related]
15. Rational integration of radiation and chemotherapy in patients with unresectable stage IIIA or IIIB NSCLC. Results from the Lung Cancer Study Group, Eastern Cooperative Oncology Group, and Radiation Therapy Oncology Group.
Wagner H
Chest; 1993 Jan; 103(1 Suppl):35S-42S. PubMed ID: 8380132
[TBL] [Abstract][Full Text] [Related]
16. First-line combination chemotherapy for advanced non-small cell lung cancer: the Eastern Cooperative Oncology Group and Southwest Oncology Group experience.
Sandler A
Semin Oncol; 1999 Oct; 26(5 Suppl 15):44-51. PubMed ID: 10566611
[TBL] [Abstract][Full Text] [Related]
17. The role of radiation therapy in thoracic tumors.
Kong FM; Zhao L; Hayman JA
Hematol Oncol Clin North Am; 2006 Apr; 20(2):363-400. PubMed ID: 16730299
[TBL] [Abstract][Full Text] [Related]
18. Locally advanced non-small cell lung cancer: the past, present, and future.
Govindan R; Bogart J; Vokes EE
J Thorac Oncol; 2008 Aug; 3(8):917-28. PubMed ID: 18670313
[TBL] [Abstract][Full Text] [Related]
19. Designing a definitive trial for adjuvant targeted therapy in genotype defined lung cancer: the ALCHEMIST trials.
Alden RS; Mandrekar SJ; Oxnard GR
Chin Clin Oncol; 2015 Sep; 4(3):37. PubMed ID: 26408304
[TBL] [Abstract][Full Text] [Related]
20. New molecular targeted therapies integrated with radiation therapy in lung cancer.
Provencio M; Sánchez A; Garrido P; Valcárcel F
Clin Lung Cancer; 2010 Mar; 11(2):91-7. PubMed ID: 20199974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
